News & Events

Body:

Global Alert: Chikungunya virus (CHIKV), spread by Aedes mosquitoes, causes fever, severe arthritis, and long-term joint damage. Symptoms overlap with dengue and malaria, 

but traditional testing delays treatment—critical for infants, elderly, and high-risk groups.

Rising global temperatures are intensifying yellow fever outbreaks across the Americas, with forest transmission escalating and cross-border risks soaring! High fatality rates

and vaccine gaps sound the alarm – echoing the recent surge of Chikungunya. This warns us: Vector-borne viruses are spreading globally, making early diagnosis and treatment critical!

Introducing GenDx VBP6 Multiplex Test:

Powered by patented ERA Isothermal Amplification Technology (Patents: ZL201910262085.3 / WO2020199342A1):

✅ Results in 20 mins – No complex instruments, deployable in clinics

✅ Detects 6 pathogens in one tube: CHIKV, dengue, malaria parasites, and more

✅ Ultra-sensitive – Billions-fold DNA/RNA amplification at low temperatures

Key Innovations:

• Engineered enzymes via protein-directed evolution

• Isothermal amplification (7-10 mins)

• Outperforms PCR in speed and simplicity

Transformative Impact:

Enables lab-accurate, point-of-care testing to:

• Guide precise treatment (avoid misdiagnosis)

• Accelerate outbreak screening

• Strengthen border health security

Act Now for Faster Diagnosis